Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03319277 · ClinicalTrials.gov registry record · NA
A Randomized-controlled Trial of Post-operative Opiate Quantities After Urogynecologic Surgery
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 118
- Enrollment target
NCT03319277 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 118 participants.
The verdict
NCT03319277, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 118 participants
- Enrollment target
Study Summary
This is a randomized controlled trial to determine the effect of decreased post-operative prescriptions of opiate medications after urogynecologic surgery.
Interventions
- OTHER Decreased opiate prescription
- OTHER Routine opiate prescription
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2017-10-13 |
| Est. Completion | 2019-06-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03319277
The ClinicalTrials.gov registry entry for NCT03319277 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Decreased opiate prescription is the first listed.
NCT03319277 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03319277 about?
NCT03319277 is a clinical study titled "A Randomized-controlled Trial of Post-operative Opiate Quantities After Urogynecologic Surgery". This is a randomized controlled trial to determine the effect of decreased post-operative prescriptions of opiate medications after urogynecologic surgery.
What is the current status of trial NCT03319277?
This trial is currently completed. It is a NA study. The enrollment target is 118 participants. The study started on 2017-10-13. Estimated completion is 2019-06-25.
What interventions are being tested in trial NCT03319277?
The interventions under investigation include: Decreased opiate prescription (OTHER), Routine opiate prescription (OTHER).
Who is sponsoring clinical trial NCT03319277?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.